{"pmid":32444414,"title":"Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.","text":["Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.","Ann Rheum Dis","Megremis, Spyridon","Walker, Thomas D J","He, Xiaotong","Ollier, William E R","Chinoy, Hector","Hampson, Lynne","Hampson, Ian","Lamb, Janine A","32444414"],"journal":"Ann Rheum Dis","authors":["Megremis, Spyridon","Walker, Thomas D J","He, Xiaotong","Ollier, William E R","Chinoy, Hector","Hampson, Lynne","Hampson, Ian","Lamb, Janine A"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444414","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217522","keywords":["autoantibodies","autoimmune diseases","dermatomyositis"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1667600475944386560,"score":9.490897,"similar":[{"pmid":32453861,"title":"Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","text":["Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated.","Br J Haematol","Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco","32453861"],"abstract":["This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated."],"journal":"Br J Haematol","authors":["Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453861","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16883","keywords":["ankirin 1","autoantibodies","autoimmunity","covid-19","molecular mimicry","severe acute respiratory syndrome coronavirus 2"],"topics":["Mechanism"],"weight":1,"_version_":1667983494521815040,"score":68.51737},{"pmid":32401346,"title":"SARS-CoV-2 immunogenicity at the crossroads.","text":["SARS-CoV-2 immunogenicity at the crossroads.","The outbreak of coronavirus disease 2019 (COVID-19) caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health emergency and became a worldwide pandemic. We summarize the recent findings with respect to the function, structure and immunogenicity of the spike (S) protein, arising mutations, and implications on vaccine development and therapeutics.","Allergy","Karamloo, Fariba","Konig, Renate","32401346"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health emergency and became a worldwide pandemic. We summarize the recent findings with respect to the function, structure and immunogenicity of the spike (S) protein, arising mutations, and implications on vaccine development and therapeutics."],"journal":"Allergy","authors":["Karamloo, Fariba","Konig, Renate"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401346","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/all.14360","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666865855030362114,"score":57.371002},{"pmid":32341791,"pmcid":"PMC7174058","title":"Thoughts on COVID-19 and autoimmune diseases.","text":["Thoughts on COVID-19 and autoimmune diseases.","Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.","Lupus Sci Med","Askanase, Anca D","Khalili, Leila","Buyon, Jill P","32341791"],"abstract":["Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia."],"journal":"Lupus Sci Med","authors":["Askanase, Anca D","Khalili, Leila","Buyon, Jill P"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341791","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/lupus-2020-000396","keywords":["autoimmune diseases","cytokines","inflammation"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Chloroquine","tocilizumab","baricitinib"],"topics":["Treatment"],"weight":1,"_version_":1666138495775670272,"score":56.522396},{"pmid":32387238,"title":"Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?","text":["Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?","Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications, with frequent fatal issues, occur in others. Disease severity is associated with age and comorbidities. Understanding of viral infectious mechanisms, and antibody immune response, can help to better control disease progression. SARS-CoV-2 has a major impact on the Renin Angiotensin Aldosterone System (RAAS), through its binding to the membrane cellular glycoprotein, Angiotensin Converting Enzyme-2 (ACE-2), then infecting cells for replication. This report hypothesizes the possible implication of an autoimmune response, induced by generation of allo- or autoantibodies to ACE-2, or to its complexes with viral spike protein. This could contribute to some delayed severe complications occurring in affected patients. We also propose a strategy for investigating this eventuality.","Transfus Apher Sci","Amiral, Jean","Vissac, Anne Marie","Seghatchian, Jerard","32387238"],"abstract":["Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications, with frequent fatal issues, occur in others. Disease severity is associated with age and comorbidities. Understanding of viral infectious mechanisms, and antibody immune response, can help to better control disease progression. SARS-CoV-2 has a major impact on the Renin Angiotensin Aldosterone System (RAAS), through its binding to the membrane cellular glycoprotein, Angiotensin Converting Enzyme-2 (ACE-2), then infecting cells for replication. This report hypothesizes the possible implication of an autoimmune response, induced by generation of allo- or autoantibodies to ACE-2, or to its complexes with viral spike protein. This could contribute to some delayed severe complications occurring in affected patients. We also propose a strategy for investigating this eventuality."],"journal":"Transfus Apher Sci","authors":["Amiral, Jean","Vissac, Anne Marie","Seghatchian, Jerard"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387238","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.transci.2020.102804","keywords":["ace-2","angiotensin ii","autoantibodies","covid-19","disease severity","hemostasis","spike protein s"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666428892715417600,"score":55.35539},{"pmid":32473352,"title":"Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.","text":["Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.","The 2019 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has caused a large number of deaths, with thousands of confirmed cases worldwide. The present study followed computational approaches to identify B- and T-cell epitopes for the spike (S) glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We identified 24 peptide stretches on the SARS-CoV-2S protein that are well conserved among the reported strains. The S protein structure further validated the presence of predicted peptides on the surface, of which 20 are surface exposed and predicted to have reasonable epitope binding efficiency. The work could be useful for understanding the immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in designing some peptide-based diagnostics. Also, identified T-cell epitopes might be considered for incorporation in vaccine designs.","Infect Genet Evol","Vashi, Yoya","Jagrit, Vipin","Kumar, Sachin","32473352"],"abstract":["The 2019 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has caused a large number of deaths, with thousands of confirmed cases worldwide. The present study followed computational approaches to identify B- and T-cell epitopes for the spike (S) glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We identified 24 peptide stretches on the SARS-CoV-2S protein that are well conserved among the reported strains. The S protein structure further validated the presence of predicted peptides on the surface, of which 20 are surface exposed and predicted to have reasonable epitope binding efficiency. The work could be useful for understanding the immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in designing some peptide-based diagnostics. Also, identified T-cell epitopes might be considered for incorporation in vaccine designs."],"journal":"Infect Genet Evol","authors":["Vashi, Yoya","Jagrit, Vipin","Kumar, Sachin"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473352","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.meegid.2020.104382","keywords":["diagnostics","epitopes","sars-cov-2","spike protein"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668255193388548096,"score":54.133957}]}